It is an honor for me to welcome you to EpiDisease SL, a leading company in the fascinating world of epigenetics. As one of the founding partners, I am excited to share our vision and passion for developing new in vitro diagnostic (IVD) tools, built on pioneering science, that will revolutionize the world for patients, clinical specialists, and healthcare providers.
In the field of epigenetics, we explore the hidden language of DNA, uncovering the secrets encoded in the unique interaction between our genes and the environment that influences our health. At EpiDisease, our mission is clear: harness the power of epigenetics to deliver innovative in vitro diagnostic solutions that empower clinical specialists to make data-driven, life-saving decisions.
Our journey is deeply rooted in cutting-edge science, driven by relentless curiosity, and fueled by a commitment to improving lives across the globe. Through rigorous research, unwavering dedication, and collaborations with top-level partners and stakeholders, we are shaping the future of healthcare.
This path is not one we walk alone. Thanks to our collaborators and partners—and after nine years of hard work—we have reached the milestone of launching our first IVD tool (ScoliGEN) to the market by the end of this year, with four more scheduled for release in 2025. All will carry CE-IVD marking, complying with the most demanding regulatory standards for clinical tools in Europe.
I invite you to explore our website to learn more about our groundbreaking work, meet our team of scientists and experts, and begin discovering the transformative potential of epigenetics.
Thank you for joining us on this extraordinary journey.
Warm regards,
